SPOTLIGHT -
Irvine, CA-When treating dry eye at all levels of severity, ophthalmic professionals need to match appropriate therapies with individual patients' needs.
Ophthalmologists embrace potential of clinically tested nutraceuticals for dry eye disease
(EyePod) From idea to impact: Navigating ophthalmic innovation
Pantheon Vision holds two pre-submission meetings with FDA
EyePod: Modifier Gene Therapy: What is it?
Study evaluates the potential correlation of ultra-processed food consumption and increased glaucoma incidence
Blog: Managing patients with MGD and Demodex blepharitis